Cardion

Cardion AG is a transatlantic biopharmaceutical company dedicated to developing novel therapies for heart disease and cell transplantation. Additionally, it develops immunosuppressive agents for stem cell transplantation and autoimmune diseases. Its products include NOStentin, a non-viral gene therapy designed to prevent restenosis. The company integrates stem cells, gene therapy toolkit technology, and novel immunotherapy proteins into a platform suite that offers products for treating heart disease, arthritis/inflammation, transplantation, and diabetes.